Cory Jubinville, PhD
Stock Analyst at LifeSci Capital
(4.72)
# 726
Out of 4,676 analysts
169
Total ratings
54.9%
Success rate
25.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville, PhD
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Reiterated: Buy | $6 | $3.71 | +61.73% | 11 | Aug 17, 2026 | |
| TNYA Tenaya Therapeutics | Maintained: Buy | $4 | $0.7014 | +470.29% | 33 | Aug 6, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.2816 | - | 14 | Jan 12, 2026 | |
| CRNX Crinetics Pharmaceuticals | Maintained: Buy | $93 → $99 | $84.86 | +16.66% | 30 | Jan 5, 2026 | |
| SION Sionna Therapeutics | Initiated Coverage: Buy | $60 | $6.25 | +860.00% | 1 | Dec 23, 2025 | |
| IKT Inhibikase Therapeutics | Initiated Coverage: Buy | $5 | $2.50 | +100.00% | 1 | Dec 1, 2025 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $88 | $37.71 | +133.36% | 5 | Nov 18, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintained: Buy | $9 | $3.78 | +138.10% | 17 | Nov 7, 2025 | |
| LRMR Larimar Therapeutics | Maintained: Buy | $22 | $4.16 | +428.85% | 21 | Nov 5, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $85 → $84 | $71.45 | +17.56% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $67 | $70.49 | -4.95% | 22 | Nov 3, 2025 |
Prime Medicine
Aug 17, 2026
Reiterated: Buy
Price Target: $6
Current: $3.71
Upside: +61.73%
Tenaya Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $4
Current: $0.7014
Upside: +470.29%
Mereo BioPharma Group
Jan 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.2816
Upside: -
Crinetics Pharmaceuticals
Jan 5, 2026
Maintained: Buy
Price Target: $93 → $99
Current: $84.86
Upside: +16.66%
Sionna Therapeutics
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $60
Current: $6.25
Upside: +860.00%
Inhibikase Therapeutics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.50
Upside: +100.00%
Tectonic Therapeutic
Nov 18, 2025
Maintained: Buy
Price Target: $88
Current: $37.71
Upside: +133.36%
Rocket Pharmaceuticals
Nov 7, 2025
Maintained: Buy
Price Target: $9
Current: $3.78
Upside: +138.10%
Larimar Therapeutics
Nov 5, 2025
Maintained: Buy
Price Target: $22
Current: $4.16
Upside: +428.85%
Tarsus Pharmaceuticals
Nov 5, 2025
Maintained: Buy
Price Target: $85 → $84
Current: $71.45
Upside: +17.56%
Nov 3, 2025
Maintained: Buy
Price Target: $54 → $67
Current: $70.49
Upside: -4.95%